Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Indapamide Sustained Release Tablets

Approval Number

国药准字H20052001

Company湖北福人福通药业有限公司

Registration Date

August 28, 2020

Previous Approval Numbers

国药准字H20052001

Drug Information

Generic Name

吲达帕胺缓释片

Brand Name

立舒平

Dosage Form

片剂

Strength

1.5mg

Drug Type

化学药品

Registration Date

August 28, 2020

Company Information

Applicant Company

Company Name湖北福人福通药业有限公司

Company Address

湖北咸安经济开发区生物医药产业园兴宁路16号

Manufacturing Company

Company Name湖北福人福通药业有限公司

Company Address

湖北咸安经济开发区生物医药产业园兴宁路16号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy